Vanda Pharmaceuticals | VNDA - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 23.11B 12.19B 2026-06
J&J USD 599.1B 54.52B 2026-10
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
Merck USD 317.37B 20.27B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pfizer USD 138.44B 15.37B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12
Veracyte USD 4.69B 2.12B 2026-06